Gu, J., Qian, L., Zhang, G., Mahajan, N. P., Owonikoko, T. K., Ramalingam, S. S., & Sun, S. (2020). Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib. Lung Cancer.

Gu, Jiajia, Luxi Qian, Guojing Zhang, Nupam P. Mahajan, Taofeek K. Owonikoko, Suresh S. Ramalingam, and Shi-Yong Sun. "Inhibition of ACK1 Delays and Overcomes Acquired Resistance of EGFR Mutant NSCLC Cells to the Third Generation EGFR Inhibitor, Osimertinib." Lung Cancer 2020.

Gu, Jiajia, et al. "Inhibition of ACK1 Delays and Overcomes Acquired Resistance of EGFR Mutant NSCLC Cells to the Third Generation EGFR Inhibitor, Osimertinib." Lung Cancer 2020.